All In Biotech

Free tool

FAERS Monitor: Arestin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050781 or its brand name (Arestin, Minocycline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,103

Serious

4,179

82% of reports

Hospitalization

2,242

Death reported

1,656

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,272
  • off label use1,161
  • drug intolerance966
  • pain929
  • rheumatoid arthritis895
  • rash793
  • nausea791
  • arthralgia775
  • drug hypersensitivity753
  • joint swelling733
  • fatigue699
  • c-reactive protein increased680
  • condition aggravated679
  • headache679
  • contraindicated product administered667

Reports by year received

View as table
YearReports
200432
200538
200644
200799
200873
200957
201043
201155
2012101
201345
2014151
2015137
2016202
2017230
2018250
2019303
2020300
2021256
2022404
2023422
2024714
2025802
2026345

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,056 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contraindicated product administeredSignal66792.886.459,246
c-reactive protein increasedSignal68078.573.151,051
drug intoleranceSignal96641.639.338,050
rheumatoid arthritisSignal89532.730.827,442
joint swellingSignal73325.223.516,987
drug hypersensitivitySignal75316.115.110,703
condition aggravatedSignal6799.28.65,032
arthralgiaSignal7757.77.24,590
rashSignal7937.57.04,555
painSignal9296.25.94,200
off label useSignal1,1615.55.24,416
headacheSignal6794.54.21,878
nauseaSignal7914.13.91,939
drug ineffectiveSignal1,2724.03.83,023
fatigueSignal6993.73.51,428

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.